DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Mizuki A, Tetemichi M, Sakakibara T. et al.
A multicenter, randomized, open-label trial: efficacy of once-daily versus twice-daily double-dose rabeprazole on refractory gastroesophageal reflux disease-related symptoms and quality of life.
Curr Ther Res Clin Exp 2016;
79: 1-7
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.